bismuth subsalicylate 35 MG/ML Oral Suspension [Kaopectate Reformulated Aug 2006]
RxNorm concept 1043048, branded drug (sbd). Prescribable name: Kaopectate Extra Strength 525 MG in 15 mL Oral Suspension, Reformulated Aug 2006.
- RxCUI
- 1043048
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1043048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Kaopectate 525 MG per 15 ML Oral Suspension, Reformulated Aug 2006; Kaopectate Reformulated Aug 2006 35 MG/ML Oral Suspension
Related concepts
- bismuth subsalicylate 35 MG/ML (SCDC, consists of)
- bismuth subsalicylate 35 MG/ML [Kaopectate Reformulated Aug 2006] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Kaopectate Reformulated Aug 2006 (BN, has ingredient)
- bismuth subsalicylate 35 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 41167060505
- 53076000045
- 53076020036
- 55505020036
- 55505022964
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1043048 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1043048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1043048. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.